Skip to content

Research on the Inheritance and Innovation of Yongpai Traditional Chinese Medicine Theory in the Diagnosis and Treatment of Chronic Renal Failure

Research on the Inheritance and Innovation of Yongpai Traditional Chinese Medicine Theory in the Diagnosis and Treatment of Chronic Renal Failure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001372
Enrollment
Unknown
Registered
2025-07-09
Start date
2024-09-06
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Interventions

Traditional Chinese Medicine (TCM) Compound Formula Group for Qi Deficiency with Blood Stasis Pattern:Yiqi Xiaozheng Formula+Standard Treatment
Control Group with Yang Deficiency and Blood Stasis Pattern:Standard Treatment
Healthy Control Group:Non-Intervention Control
Control Group with Qi Deficiency and Blood Stasis Pattern:Standard Treatment
Traditional Chinese Medicine (TCM) Compound Formula Group for Yin Deficiency with Blood Stasis Pattern:Buxu Xiaozheng Formula+Standard Treatment
Control Group with Yin Deficiency and Blood Stasis Pattern:Standard Treatment
Traditional Chinese Medicine (TCM) Compound Formula Group for Yang Deficiency with Blood Stasis Pattern:Wenyang Xiaozheng Formula+Standard Treatment

Sponsors

Ningbo Municipal Hospital of Traditional Chinese Medicine(TCM) Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Chronic Kidney Disease (CKD) Patients:1)Meeting the Western diagnostic criteria for chronic kidney disease (CKD stages 3-5);2)TCM syndrome differentiation consistent with:Qi deficiency with blood stasis or Yang deficiency with blood stasis or Yin deficiency with blood stasis;3)Age between 18–75 years;4)Controlled comorbidities including infections acidosis electrolyte imbalances and hypertension;5)Willingness to participate with signed informed consent for clinical research. Inclusion Criteria for Healthy Controls1)Healthy volunteers (non-therapeutic participation) without diseases relevant to the study;2)Healthy volunteers (non-therapeutic participation) without diseases relevant to the study;3)Availability of complete medical records and signed informed consent.

Exclusion criteria

Exclusion criteria: 1)Pregnancy or lactation;2)Severe comorbidities including:major primary diseases of the heart brain liver or hematopoietic systemsevere infectionsmalignancy (cancer)allergy/hypersensitivity to the investigational drugs;3)Non-cooperative patients such as those with psychiatric disorders affecting compliance;4)Refusal to participate including:unwillingness to undergo treatmentdeclining to sign the informed consent form. Any of the above conditions will lead to exclusion from the study.

Design outcomes

Primary

MeasureTime frame
Renal function;

Secondary

MeasureTime frame
Hemoglobin;Serum Calcium;Serum Albumin;Urine Protein-to-Creatinine Ratio;Serum Phosphorus;Traditional Chinese Medicine (TCM) Symptom Score;Parathyroid Hormone;Serum Beta Microglobulin;Lipid Profile;

Countries

CHINA

Contacts

Public ContactCai Xudong

Ningbo Municipal Hospital of Traditional Chinese Medicine(TCM) Affiliated Hospital of Zhejiang Chinese Medical University

13777124877@163.com13777124877

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026